SoftCath

OCTOBER 31, 2021

Since the onset of COVID-19, cardiology care has been under extreme risk and adverse complications. So, let’s unwind how the innovations in cath lab software are reshaping the method of cardiovascular care post-Covid-19. Cath lab management software , which existed even before COVID-19, experienced updates and upgrades.

COVID-19 52

COVID-19 Innovation Cardiac Rehabilitation Cardiovascular Disease 52

American College of Cardiology

OCTOBER 23, 2024

In this week’s View, Dr. Eagle looks at anthracycline cardiotoxicity in treatment of cancer patients.

COVID-19 52

COVID-19 Cancer Cholesterol Arrhythmia 52

Open Heart

MARCH 16, 2023

Background The COVID-19 pandemic accelerated the uptake of digital health interventions for the delivery of cardiac rehabilitation (CR). However, there is a need to evaluate these interventions. Methods We examined the impact of an evidence-based, digital CR programme on medical, lifestyle and psychosocial outcomes. kg, p<0.001).

COVID-19 52

COVID-19 Cardiac Rehabilitation Blood Pressure Diet 52

Circulation: Cardiovascular Quality & Outcomes

NOVEMBER 6, 2023

Background:Low-income working-age US adults disproportionately experienced healthcare disruptions at the onset of the COVID-19 pandemic. 0.98]) and cholesterol testing (RR 0.93 [0.91-0.96]) Circulation: Cardiovascular Quality and Outcomes, Ahead of Print. However, routine visits (RR 0.96 [0.94-0.98]) 1.08]) remained stable.

Risk Factors 40

Risk Factors Medicaid COVID-19 Outpatient 40

Frontiers in Cardiovascular Medicine

JANUARY 13, 2025

IntroductionThe COVID-19 pandemic, starting in 2020, raised concerns about potential long-term health impacts, including its effects on cardiovascular health and related biomarkers. The study observed modest declines in mean glucose, cholesterol, HDL, and LDL levels post-pandemic, with stable blood pressure.

COVID-19 52

COVID-19 Blood Pressure Cholesterol Biomarkers 52

Heart 2023 Conference

APRIL 20, 2022

(Open JAMA Network) According to findings given at the European Congress of Clinical Microbiology and Infectious Diseases, COVID-19 is more severe in patients with a high cardiovascular risk, even if they don't have any current cardiovascular illness.

Pulmonary 52

Pulmonary Hypertension AFIB COVID-19 52

DAIC

JANUARY 25, 2024

The continuing trend reverses improvements achieved in the decade before the COVID-19 pandemic to reduce mortalities from heart disease and stroke , the leading causes of death in the United States. The findings are reported in the American Journal of Preventive Medicine , published by Elsevier.

COVID-19 117

COVID-19 Public Health Heart Disease Chronic Disease 117